SearchDictionaryMobileLogin

Type I IFN protects against murine lupus.

AbstractBoth the type I (IFN-alpha beta) and type II (IFN-gamma) IFNs have been heavily implicated in the pathogenesis of systemic lupus erythematosus. To test the relative roles of these systems, congenic lupus-prone MRL/CD95(lpr/lpr) (MRL/lpr) mice lacking the type I IFN receptor (IFN-RI), type II IFN receptor (IFN-RII), or both, were derived. As expected, deficiency for IFN-RII protected MRL/lpr mice from the development of significant autoimmune-associated lymphadenopathy, autoantibodies, and renal disease. However, deficiency for the IFN-RI surprisingly worsened lymphoproliferation, autoantibody production, and end organ disease; animals doubly deficient for IFN-RI and IFN-RII developed an autoimmune phenotype intermediate between wild-type and IFN-RII-deficient animals, all correlating with an ability of type I IFN to suppress MRL B cell activation. Thus, type I IFNs protect against both the humoral and end organ autoimmune syndrome of MRL/lpr mice, independent of IFN-gamma. These findings warrant caution in the use of type I IFN antagonists in the treatment of autoimmune diseases and suggest further investigation into the interplay between the types I and II IFNs during the ontogeny of pathogenic autoantibodies.
AuthorsJonathan D Hron, Stanford L Peng (Affiliation: Department of Internal Medicine , Washington University School of Medicine, St. Louis, MO 63110, USA.)
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 173 Issue 3 Pg. 2134-42 (Aug 1 2004) ISSN: 0022-1767 United States
PMID15265950 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Antinuclear
  • Interferon-alpha
  • Membrane Proteins
  • Receptors, Interferon
  • interferon receptor, type II
  • Receptor, Interferon alpha-beta
  • Interferon-beta
  • Rheumatoid Factor
Topics
  • Animals
  • Antibodies, Antinuclear (biosynthesis)
  • Autoimmune Diseases (genetics, pathology, physiopathology, prevention & control)
  • B-Lymphocytes (immunology)
  • Crosses, Genetic
  • Disease Models, Animal
  • Female
  • Interferon-alpha (physiology)
  • Interferon-beta (physiology)
  • Kidney Glomerulus (pathology)
  • Liver (pathology)
  • Lung (pathology)
  • Lupus Erythematosus, Systemic (genetics, pathology, physiopathology, prevention & control)
  • Lupus Nephritis (pathology, physiopathology, prevention & control)
  • Lymphocyte Activation
  • Lymphoproliferative Disorders (genetics, physiopathology)
  • Male
  • Membrane Proteins
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred MRL lpr
  • Receptor, Interferon alpha-beta
  • Receptors, Interferon (deficiency, genetics, physiology)
  • Rheumatoid Factor (biosynthesis)
  • Salivary Glands (pathology)